[1]
E. Antonijević Miljaković et al., “Adverse outcome pathways as a new approach to assess toxicity in drug development”, arhfarm, vol. 72, no. Suppl. 4, pp. S131-S132, Oct. 2022, Accessed: Nov. 19, 2026. Available: https://test.aseestant.ceon.rs/index.php/arhfarm/article/view/38542